China to launch counterfeit drug crackdown
Updated: 2012-02-17 17:11
(Xinhua)
|
|||||||||
BEIJING - China's drug regulatory agency will launch a four-month crackdown concentrating on the production and sale of counterfeit medicine.
The crackdown will focus on pharmaceutical producers' failure to follow proper drug formulae during the production process, as well as the use of adulterated ingredients, according to a Friday statement from the State Food and Drug Administration.
The production of unlicensed drugs, as well as the practices of leasing property and equipment to produce unlicensed drugs, will also be a focus of the campaign, the statement said.
The campaign will also cover the sale of medicine from illegal sources, as well as forgeries of purchase and sale documents and violations of regulations on the sale of prescription drugs, the statement said.
Violators may have their production and sale permits revoked, and the administration plans to publicize any cases of counterfeiting that it uncovers, the statement said.
- Relief reaches isolated village
- Rainfall poses new threats to quake-hit region
- Funerals begin for Boston bombing victims
- Quake takeaway from China's Air Force
- Obama celebrates young inventors at science fair
- Earth Day marked around the world
- Volunteer team helping students find sense of normalcy
- Ethnic groups quick to join rescue efforts
Most Viewed
Editor's Picks
Supplies pour into isolated villages |
All-out efforts to save lives |
American abroad |
Industry savior: Big boys' toys |
New commissioner
|
Liaoning: China's oceangoing giant |
Today's Top News
Health new priority for quake zone
Xi meets US top military officer
Japan's boats driven out of Diaoyu
China mulls online shopping legislation
Bird flu death toll rises to 22
Putin appoints new ambassador to China
Japanese ships blocked from Diaoyu Islands
Inspired by Guan, more Chinese pick up golf
US Weekly
Beyond Yao
|
Money power |